Greppmair, Sebastian
Brinkmann, Alexander
Roehr, Anka
Frey, Otto
Hagel, Stefan
Dorn, Christoph
Marsot, Amélie
El-Haffaf, Ibrahim
Zoller, Michael
Saller, Thomas
Zander, Johannes
Schatz, Lea Marie
Scharf, Christina
Briegel, Josef
Minichmayr, Iris K.
Wicha, Sebastian G.
Liebchen, Uwe http://orcid.org/0000-0002-4375-0923
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (504995322)
Universitätsklinik München
Article History
Received: 5 April 2023
Accepted: 27 June 2023
First Online: 13 July 2023
Declarations
:
: AB reports lecture fees and support for attending meetings from Fresenius Medical Care (FMC), MSD Sharp & Dohme GmbH, Pfizer Pharma GmbH, Verein zur Förderung der GHE e.V. (Hannover), Labor Limbach and participation on an Advisory Board at Stuttgarter Intensivkongress (SIK), Anästhesie und Intensivmedizin (Journal), Antibiotics (Journal). OF declares honoraria for lectures and presentations of MSD Germany and Fresenius Kabi Germany. SH reports grants from the Federal Ministry of Education and Research (BMBF), lecture fees from Pfizer, MSD, InfectoPharm, Advanz and Philips, and support for attending meetings from Pfizer and Advanz. MZ received funding of research from CytoSorbents Europe GmbH and was part of the Advisory Board at Gilead Ambisome. TS declares funding by the Munich Clinician-Scientist Program (Faculty of Medicine, LMU Munich) and serves as a speaker for the program. CS reports speaker honoraria from CytoSorbents Europe GmbH. UL reports consulting fees from CytoSorbents Europe GmbH. SGW reports consulting fees from Merck KGaA and Medicines for Malaria Venture, research grants from Boehringer Ingelheim, as well as speaker honoraria from GSK. SGW is the founder and lead developer of the TDMx project (TDMx.eu).
: Ethical approval for this study was waived by the local institutional review board (No.: 21-1162 KB).
: All authors read and approved the final manuscript for submission.